Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02667587 |
|---|---|
| Brief Title: | An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) (CheckMate548) |
| First Submitted : | January 26, 2016 |
| First Submitted that Met QC Criteria : | January 26, 2016 |
| First Posted : | January 29, 2016 (Estimate) |
| Results First Submitted : | November 30, 2021 |
| Results First Submitted that Met QC Criteria : | January 6, 2022 |
| Results First Posted : | February 3, 2022 |
| Last Update Submitted that Met QC Criteria : | December 22, 2022 |
| Last Update Posted : | December 27, 2022 |